日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3D Printing for Cardiovascular Applications: From End-to-End Processes to Emerging Developments

3D打印在心血管领域的应用:从端到端流程到新兴发展

Gharleghi, Ramtin; Dessalles, Claire A; Lal, Ronil; McCraith, Sinead; Sarathy, Kiran; Jepson, Nigel; Otton, James; Barakat, Abdul I; Beier, Susann

Platelet Quiescence in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Bypass Graft Surgery

接受冠状动脉旁路移植术的急性冠脉综合征患者的血小板静止状态

Sarathy, Kiran; Wells, George A; Singh, Kuljit; Couture, Etienne; Chong, Aun Yeong; Rubens, Fraser; Lordkipanidzé, Marie; Tanguay, Jean-François; So, Derek

Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic

冠状动脉血运重建术后可改变的危险因素和残余风险:来自区域性专科随访诊所的见解

Simard, Trevor; Jung, Richard G; Di Santo, Pietro; Harnett, David T; Abdel-Razek, Omar; Ramirez, F Daniel; Motazedian, Pouya; Parlow, Simon; Labinaz, Alisha; Moreland, Robert; Marbach, Jeffrey; Poulin, Anthony; Levi, Amos; Majeed, Kamran; Boland, Paul; Couture, Etienne; Sarathy, Kiran; Promislow, Steven; Russo, Juan J; Chong, Aun Yeong; So, Derek; Froeschl, Michael; Dick, Alexander; Labinaz, Marino; Le May, Michel; Holmes, David R Jr; Hibbert, Benjamin

Letter to the Editor: CSANZ Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand

致编辑的信:澳大利亚和新西兰心脏病学会 (CSANZ) 关于 COVID-19 大流行期间澳大利亚和新西兰介入心脏病服务提供的共识指南

Sarathy, Kiran; Pitney, Mark; Konecny, Pamela; Jepson, Nigel

Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.

血浆腺苷作为心血管风险标志物的评价:分析和生物学考虑因素

Simard Trevor, Jung Richard, Labinaz Alisha, Faraz Mohammad Ali, Ramirez F Daniel, Di Santo Pietro, Perry-Nguyen Dylan, Pitcher Ian, Motazedian Pouya, Gaudet Chantal, Rochman Rebecca, Marbach Jeffrey, Boland Paul, Sarathy Kiran, Alghofaili Saleh, Russo Juan J, Couture Etienne, Promislow Steven, Beanlands Rob S, Hibbert Benjamin